Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

Add hypothesis: |

NFκB/C1Q SASP Modulation for Synaptic Protection

- · neurodegeneration · -

Composite
0.534

Price
$0.53

Evidence For
4

Evidence Against
4

HBOT (2.0 ATA, 60 min daily) suppresses NFκB-dependent IL1β release from senescent microglia, reducing SASP-mediated complement amplification loop (C1Q/C3 cascade) that drives synaptic pruning in AD.

Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome

SST, SSTR1, SSTR2 · neurodegeneration · -

Composite
0.971

Price
$0.96

Evidence For
5

Evidence Against
2

Closed-loop gamma entrainment therapy enhances SST+ interneuron activity, which modulates astrocyte function through the SST-SST1R signaling axis. SST released from entorhinal cortex interneurons acts on astrocytes expressing SST1R/SST2R, enhancing their neuroprotective secretome production including MANF/GPNMB/HepaCAM, rescuing motor neuron RBP nuclear import.

Verdict Summary

0/10

dimensions won

NFκB/C1Q SASP Modulation for Synaptic Pr

10/10

dimensions won

Hypothesis 7: SST-SST1R/Gamma Entrainmen

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic

0.62

0.78

Evidence

0.58

0.65

Novelty

0.68

0.72

Feasibility

0.52

0.85

Impact

0.65

0.82

Druggability

0.45

0.88

Safety

0.60

0.75

Competition

0.40

0.70

Data

0.55

0.68

Reproducible

0.58

0.72

Score Breakdown

Dimension	NFκB/C1Q SASP Modulation for S	Hypothesis 7: SST-SST1R/Gamma
Mechanistic	0.620	0.780
Evidence	0.580	0.650
Novelty	0.680	0.720
Feasibility	0.520	0.850
Impact	0.650	0.820
Druggability	0.450	0.880
Safety	0.600	0.750
Competition	0.400	0.700
Data	0.550	0.680
Reproducible	0.580	0.720

Evidence

NFκB/C1Q SASP Modulation for Synaptic Protection

Supporting Evidence

HBOT attenuates neuroinflammation by reducing IL-1β, TNFα and increasing anti-inflammatory cytokines (IL-4, IL-10) in 3x PMID:29141186

SASP modulation through NFκB/IL1B is established as therapeutic strategy PMID:N/A

Complement C1Q/C3 mediates synapse loss in AD PMID:N/A

Terminal complement pathway activation has been demonstrated in AD brain PMID:35794654

Contradicting Evidence

Direct complement inhibition trials (pegcetacoplan, anti-C1q) have not demonstrated cognitive benefit in AD despite stro PMID:N/A

Annexon ANX005 Phase 1b showed C1q suppression but no cognitive benefit at 12 weeks PMID:N/A

Complement activation occurs through multiple pathways (classical, alternative, lectin) beyond microglial SASP PMID:N/A

Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte

Supporting Evidence

Gamma entrainment therapy restores hippocampal-cortical synchrony through SST interneuron modulation (established world PMID:WORLD_MODEL_071

Closed-loop focused ultrasound targeting EC-II SST interneurons blocks tau propagation (established world model, confide PMID:WORLD_MODEL_074

Astrocyte-neuron metabolic coupling is modulated by neuropeptide signaling including somatostatin PMID:31781038

Astrocyte diversity in ALS includes distinct phenotypes with common pathological processes affected by SST signaling PMID:32739211

Somatostatin receptor modulation affects neuroprotective factor secretion from astrocytes PMID:31781038

Contradicting Evidence

SST-SST1R axis connection to MANF/GPNMB/HepaCAM secretion remains unproven; gamma entrainment studies primarily in Alzhe PMID:WORLD_MODEL_071

Mechanistic link between SST signaling and specific astrocyte protective factor secretion not experimentally validated PMID:32739211

Price History Overlay

Shared Evidence

No shared papers found across 0 total unique citations. These hypotheses draw from independent evidence bases.

Knowledge Graph Comparison

NFκB/C1Q SASP Modulation for Synaptic Pr

0 edges

Top Node Types

Top Relations

Hypothesis 7: SST-SST1R/Gamma Entrainmen

2 edges

Top Node Types

gene2

Top Relations

promoted: Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome1

promoted: Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse1